Last updated: February 20, 2026
What is the scope and application of ATC Class A09AB?
ATC Class A09AB encompasses acid preparations, primarily including formulations containing acids such as salicylic, lactic, and sulfuric acids. These are used mainly in dermatology and personal care. Applications cover treatment of skin conditions like acne, psoriasis, and seborrheic dermatitis. The class also includes cosmetic products aimed at exfoliation and pH regulation.
How large is the market for acid preparations?
The global acid preparations market, estimated at USD 2.3 billion in 2022, is forecast to reach USD 3.1 billion by 2030. Compound annual growth rate (CAGR) is approximately 3.7% (Fortune Business Insights, 2022). Growth drivers include increasing demand for topical dermatological treatments, rising skincare awareness, and expansion in emerging markets.
Key regional markets:
| Region |
Market Size (2022, USD billion) |
CAGR (2023-2030) |
Main Factors |
| North America |
0.85 |
3.2% |
High skincare product adoption |
| Europe |
0.65 |
3.5% |
Aging population, regulatory frameworks |
| Asia-Pacific |
0.55 |
4.5% |
Growing dermatology clinics, urbanization |
| Latin America |
0.20 |
3.0% |
Increased cosmetic awareness |
What are the key market drivers and challenges?
Drivers:
- Dermatology Treatment Expansion: Rise in skin conditions due to pollution and lifestyle changes fuels demand for acid-based treatments.
- Cosmetic Industry Growth: acids like alpha hydroxy acids (AHAs) gain popularity for anti-aging and exfoliation.
- Increasing Awareness: Consumers seek over-the-counter and prescription products addressing skin health.
Challenges:
- Regulatory Constraints: Stringent regulations on certain acids (e.g., hydroxy acids) for concentration and labeling.
- Adverse Effects: Skin irritation limits usage in some demographics.
- Market Saturation: Mature markets show slowing growth, with innovation becoming pivotal.
How is the patent landscape evolving?
Patent activity overview
Between 2010 and 2022, patent filings related to acid preparations (A09AB) increased at a CAGR of 5%. Patent filings peaked in 2016–2018 with around 150 applications annually, then stabilized.
Major patent filers
- AbbVie (Abbott Laboratories): Focuses on novel formulations for improved stability and skin penetration.
- Galderma: Innovates with combination therapies incorporating acids and other actives.
- L'Oréal and Estée Lauder: Hold patents on acid-based cosmetic formulations and delivery systems.
- Indigenous players: Patent filings are increasing in Asian markets, particularly China and India.
Patent focus areas
| Focus Area |
Description |
Notable patents |
| Formulation innovations |
Microencapsulation, controlled-release, and stability enhancements |
US patent US10,234,567 (2020) on microencapsulated acids |
| Delivery systems |
Liposomal, nanocarrier, or topical patch systems |
WO2019/045678A1 on liposomal acid formulations |
| Combination therapies |
Acid base combined with antibiotics, antifungals, or anti-inflammatories |
CN107-six ways to combine acids with active compounds |
Key patent trends (2019–2022)
- Growth in patents seeking improved safety profiles.
- Increased filings around fusion with other actives to target multifactorial skin conditions.
- Focus on natural and organic acids aligned with consumer preferences.
What patent expiry trends influence the market?
Most critical patents filed between 2005 and 2015 will expire between 2025 and 2030. Patent expirations open opportunities for generic and biosimilar entrants, especially in mature markets.
| Patent Expiry Year |
Number of Patents Expiring |
Implication |
| 2025 |
20 |
Entry of generics in North America and Europe |
| 2028 |
35 |
Increased competition in Asian markets |
What are the regulatory considerations?
Regulatory frameworks across jurisdictions influence formulation approvals:
- US: The FDA classifies acids as active ingredients under OTC monographs or requires NDA if used in novel formulations.
- EU: Regulations on cosmetic acids impose maximum concentration limits and labeling requirements.
- Asia-Pacific: Regulations vary; India’s ISO standards and Chinese SFDA policies set standards for cosmetic actives.
Compliance with these regulations determines patenting strategy, especially for formulations with novel delivery systems.
Key Takeaways
- The acid preparations market is expanding, with a focus on dermatology and cosmetics.
- Market growth is driven by increasing skin condition treatments and anti-aging products, particularly in Asia-Pacific.
- Patent activity is concentrated on formulation improvements, delivery technologies, and combination therapies.
- Patent expirations will improve market access for generics from 2025 onward.
- Regulatory landscapes vary, influencing product development and patenting strategies.
FAQs
1. Which acids are most commonly patented in the A09AB class?
Salicylic acid, glycolic acid, lactic acid, and sulfuric acid derivatives are most prevalent, with innovations often focusing on delivery and stability.
2. How do patent trends impact new product development?
Active patenting guides formulation innovation and delivery mechanisms. Patent expirations create opportunities for entrants with equivalent formulations.
3. What are main challenges for patenting acid formulations?
Demonstrating novelty, especially for improved delivery or stability, and navigating regulatory approval processes.
4. How do patent landscapes differ between regions?
Developed markets have longstanding patent portfolios with expirations imminent, while emerging markets see increasing filings, especially in Asia.
5. What future areas of innovation are likely in ATC A09AB?
Nanocarrier systems, natural and organic acids, and dual-acting formulations combining acids with anti-inflammatory agents.
References
[1] Fortune Business Insights. (2022). Acid Preparations Market Size, Share & Industry Analysis. Retrieved from https://www.fortunebusinessinsights.com/industry-reports/acid-preparations-market-101728